Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of rationally designed affinity-based drug delivery systems.

Dustin J Maxwell1, Brandon C Hicks, Sarah Parsons

  • 1Department of Biomedical Engineering, Washington University, Campus Box 1097, 1 Brookings Drive, St. Louis, MO 63130-4899, USA.

Acta Biomaterialia
|May 17, 2006
PubMed
Summary

Researchers developed a novel peptide-based drug delivery system for controlled protein release. This system utilizes peptides with varying affinities to modulate drug release rates, showing promise for tissue regeneration applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Bridging the gap': exploring shared decision-making with autistic young people within an NHS Learning Disability and Autism Keyworker Programme in England.

BMC health services research·2026
Same author

The Seaport criteria for lymphocytic myocarditis: Implications for sudden death in infancy (SUDI).

Forensic science international·2025
Same author

Evidence of absence or absence of evidence? A commentary on 'Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease' by Paratz et al.

European journal of preventive cardiology·2025
Same author

The SCVP and AECVP 'Seaport criteria' for lymphocytic myocarditis: Retrospective application to an autopsy cohort.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2025
Same author

Post-mortem cardiac-specific troponin-I (cTnI) to determine the cause of non-traumatic hemopericardium.

Forensic science, medicine, and pathology·2025
Same author

Strategies for developing interactional expertise: how non-autistic communication partners enable or block the effective contributions to significant conversations by autistic people.

Disability and rehabilitation·2025

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Protein Therapeutics

Background:

  • Sustained protein release in vivo is crucial for therapeutic efficacy.
  • Predicting and controlling drug release rates from delivery systems remains a significant challenge.
  • Existing systems often lack precise control over the release kinetics of protein drugs.

Purpose of the Study:

  • To develop a rational design approach for drug delivery systems enabling controlled drug release.
  • To identify and synthesize peptide domains with varying affinities for a model drug (heparin).
  • To assess the ability of these peptide-modified scaffolds to deliver and modulate protein drug activity.

Main Methods:

  • Screening of a random peptide library to identify heparin-binding peptides with low, moderate, and high affinities.

Related Experiment Videos

  • Synthesis of identified peptide domains using solid-phase chemistry.
  • Development of a mathematical model incorporating binding kinetics, drug diffusion, and matrix degradation.
  • In vitro release studies of a model drug from peptide-functionalized biomaterial scaffolds.
  • In vitro assessment of nerve growth factor (NGF) delivery and biological activity using a chick dorsal root ganglia (DRG) neurite extension model.

    • Main Results:

    • Peptide domains with varying heparin affinities were successfully identified and synthesized.
    • A mathematical model was developed to predict drug release based on binding kinetics and matrix properties.
    • In vitro studies demonstrated controlled release of the model drug from the peptide-modified scaffolds.
    • The system successfully delivered and modulated the biological activity of nerve growth factor (NGF).

    Conclusions:

    • A rational design strategy for drug delivery systems based on peptide-drug interactions was established.
    • This approach allows for the control of drug release rates from tissue-engineered scaffolds.
    • The developed system shows potential for promoting tissue regeneration in vivo through controlled protein delivery.